FDA
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
-
-
-
-
-
-
-
Amphastar receives FDA approval for generic teriparatide injection
-
-
-
-
-
-
-
Needham Upgrades Amphastar Pharmaceuticals (AMPH) to Buy
-
-
-
-
-
-
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Amphastar Pharmaceuticals (AMPH)
-
327,796 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

